Edesa Biotech, Inc.
EDSA
$2.43
$0.010.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.45% | 31.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.16% | -13.68% | |||
| Operating Income | -16.16% | 13.68% | |||
| Income Before Tax | -10.06% | 1.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.00% | 1.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.00% | 1.66% | |||
| EBIT | -16.16% | 13.68% | |||
| EBITDA | -16.33% | 13.00% | |||
| EPS Basic | 16.91% | 37.99% | |||
| Normalized Basic EPS | 11.07% | 46.04% | |||
| EPS Diluted | 16.91% | 37.99% | |||
| Normalized Diluted EPS | 11.07% | 46.04% | |||
| Average Basic Shares Outstanding | 32.36% | 58.61% | |||
| Average Diluted Shares Outstanding | 32.36% | 58.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||